Research Article
Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients
Table 1
The frequency of HeyL promoter methylation status in COVID-19 patients compared to that in the control group.
| ||||||||||||||||||||||||||||||||||||||||||
A standard normal deviate (-value) is calculated as ln(OR)/ynn{ln(OR)}. CI: confidence interval. value for comparing between the frequency of partial-methylated and unmethylated promoter of HeyL gene among COVID-19 patients and the control group. Statistically significant at . |